Transmedics Group Inc reports results for the quarter ended in September - Earnings Summary

TransMedics

03/11/2022 21:39

* Transmedics Group Inc  TMDX.OQ  reported a quarterly
adjusted
loss of 25 cents​​ per share for the quarter ended in September.
The mean expectation of five analysts for the quarter was for a
loss of 41 cents per share.
    * Revenue rose 378.3% to $25.68 million from a year ago;
analysts
expected $18.88 million. 
    * Transmedics Group Inc's reported EPS for the quarter was a
loss
of 25 cents​.
    * The mean earnings estimate of analysts had risen by
about 1% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Transmedics Group Inc shares had risen by 11.1% this
quarter and
gained 142.0% so far this year.
    * The company reported a quarterly loss of $7.43 million.
    * Wall Street's median 12-month price target for Transmedics
Group
Inc is $47.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 09:39 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.41          -0.25          Beat
 Jun. 30 2022      -0.35          -0.41          Missed
 Mar. 31 2022      -0.38          -0.38          Met
 Dec. 31 2021      -0.42          -0.46          Missed